Nonresponders to Ranibizumab Anti-VEGF Treatment Are Actually Short-term Responders: A Prospective Spectral-Domain OCT Study
Bontzos, Georgios, Saghar Bagheri, Larissa Ioanidi, Ivana Kim, Ioannis Datseris, Evangelos Gragoudas, Stamatina Kabanarou, Joan Miller, Miltiadis Tsilimbaris, and Demetrios Vavvas. 2020. “Nonresponders to Ranibizumab Anti-VEGF Treatment Are Actually Short-Term Responders: A Prospective Spectral-Domain OCT Study”. Ophthalmol Retina 4 (12): 1138-45.